UnitedHealth Group (UNH Stock) Q3 earnings outlook
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERUnitedHealth Group (UNH) which is traded on the New York Stock Exchange, is a healthcare company that aims to help everyone live a healthier life and make the health system work better. UnitedHealth Group offers a wide range of products and services through two different platforms, namely UnitedHealthcare, which provides health protection and benefits services, and Optum, which provides information technology services in healthcare. UNH will report its 3rd quarter financial report on Thursday October 14, 2021, before the market opens.
In its Q2 earnings report published last July, UNH reported stronger growth and more diversity. The economic recovery and increasing demand for healthcare showed an encouraging recovery in 2021 after it experienced a decline in demand during the movement restrictions at the beginning of the Covid-19 pandemic. UNH reported revenue increased 15% to $71.30 billion. Return per share (EPS) in the 2nd quarter was reported at $4.70 (versus the $4.43 projection). Overall, UNH reported consistent sales and EPS results and has exceeded analyst projections over the past four quarterly reports, and it is expected to once again report positive financial results for the third quarter.
Market analysts at Zacks project UNH to be among the companies with the potential to sustain growth and release encouraging financial reports in the 3rd quarter following UNH’s history of consistently surpassing market analysts’ projections. Based on projections from CNN Business, UNH analysts’ consensus projections are expected to report sales revenue of $71.3 billion in the 3rd quarter, unchanged from the 2nd quarter, while the EPS consensus is for $4.41, down slightly by -6.9% from the previous quarter. The annual EPS projection for 2021 is expected at $18.75, up from $16.88 in 2020 (an increase of 11.09%).
SUMBER: CNN Business
Technical analysis #UnitedHealth (MT5)
Shares of #UnitedHealth have shown an encouraging rise in 2021, recording the highest price level in its history at 431.36, a 35% increase from the lowest price of 2021 in January at 320.00. This increase is in line with the increase in the major US bourses, namely US30 and US500, which also recorded increases. But now it is down a bit at 402.97, slightly below the daily MA50. The 382.88 level (Oct 1 low) is the nearest support.
CNN Business forecasts put #UnitedHealth shares as expected to rise for the next 12 months with the median price at 465.00, the highest projection at 522.00 while the low projection is 421.00. 23 analysts place the stock in the BUY rating category with only one placing the stock “underperform”.
UnitedHealth Group (UNH) which is traded on the New York Stock Exchange, is a healthcare company that aims to help everyone live a healthier life and make the health system work better. UnitedHealth Group offers a wide range of products and services through two different platforms, namely UnitedHealthcare, which provides health protection and benefits services, and Optum, which provides information technology services in healthcare. UNH will report its 3rd quarter financial report on Thursday October 14, 2021, before the market opens.
In its Q2 earnings report published last July, UNH reported stronger growth and more diversity. The economic recovery and increasing demand for healthcare showed an encouraging recovery in 2021 after it experienced a decline in demand during the movement restrictions at the beginning of the Covid-19 pandemic. UNH reported revenue increased 15% to $71.30 billion. Return per share (EPS) in the 2nd quarter was reported at $4.70 (versus the $4.43 projection). Overall, UNH reported consistent sales and EPS results and has exceeded analyst projections over the past four quarterly reports, and it is expected to once again report positive financial results for the third quarter.
Market analysts at Zacks project UNH to be among the companies with the potential to sustain growth and release encouraging financial reports in the 3rd quarter following UNH’s history of consistently surpassing market analysts’ projections. Based on projections from CNN Business, UNH analysts’ consensus projections are expected to report sales revenue of $71.3 billion in the 3rd quarter, unchanged from the 2nd quarter, while the EPS consensus is for $4.41, down slightly by -6.9% from the previous quarter. The annual EPS projection for 2021 is expected at $18.75, up from $16.88 in 2020 (an increase of 11.09%).
SUMBER: CNN Business
Technical analysis #UnitedHealth (MT5)
Shares of #UnitedHealth have shown an encouraging rise in 2021, recording the highest price level in its history at 431.36, a 35% increase from the lowest price of 2021 in January at 320.00. This increase is in line with the increase in the major US bourses, namely US30 and US500, which also recorded increases. But now it is down a bit at 402.97, slightly below the daily MA50. The 382.88 level (Oct 1 low) is the nearest support.
CNN Business forecasts put #UnitedHealth shares as expected to rise for the next 12 months with the median price at 465.00, the highest projection at 522.00 while the low projection is 421.00. 23 analysts place the stock in the BUY rating category with only one placing the stock “underperform”.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.